Back to Natixis Natixis

MRNA

29 quarters

Position history for NatixisNatixis's holdings in Moderna, Inc.

Yes. Natixis holds 66,370 shares of MRNA (Moderna), worth $4.6M, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$4.6M

Current Shares

66,370

Total Value Change

+$4M

Total Shares Change

+34,749

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
66,370
-
$4.6M0.0%$70.03
37
2026-Q1
Exited
0
-100.0%
$00.0%$50.80
0
2025-Q4
New
165,763
-
$4.9M0.0%$29.49
37
2025-Q3
Exited
0
-100.0%
$00.0%$25.33
0
2025-Q2
New
99,111
-
$2.7M0.0%$27.16
36
2025-Q1
Exited
0
-100.0%
$00.0%$31.12
0
2024-Q4
Increased
113,966
+78.0%
$4.7M0.0%$41.58
41
2024-Q3
Decreased
64,013
-74.1%
$4.3M0.0%$65.75
0
2024-Q2
New
246,806
-
$29.3M0.2%$118.75
48
2024-Q1
Exited
0
-100.0%
$00.0%$106.56
0
2023-Q4
Increased
49,769
+1495.2%
$4.9M0.0%$99.45
43
2023-Q3
Decreased
3,120
-70.5%
$322,2650.0%$103.29
0
2023-Q2
Increased
10,564
+228.1%
$1.3M0.0%$122.11
41
2023-Q1
New
3,220
-
$494,5280.0%$147.44
33
2022-Q4
Exited
0
-100.0%
$00.0%$179.62
0
2022-Q3
Decreased
154,124
-33.7%
$18.7M0.1%$118.07
0
2022-Q2
Increased
232,404
+313.7%
$33.2M0.1%$142.81
56
2022-Q1
Decreased
56,181
-67.1%
$9.7M0.0%$174.92
0
2021-Q4
Decreased
170,873
-47.5%
$43.4M0.1%$251.60
0
2021-Q3
Increased
325,686
+28.0%
$125.3M0.4%$378.90
45
2021-Q2
Decreased
254,517
-65.2%
$59.8M0.3%$234.46
0
2021-Q1
Increased
730,374
+87.3%
$95.6M0.3%$118.49
56
2020-Q4
Increased
389,909
+403.1%
$40.7M0.1%$111.13
56
2020-Q3
Decreased
77,493
-69.3%
$5.5M0.0%$70.52
0
2020-Q2
New
252,674
-
$16.2M0.1%$62.08
47
2019-Q4
Exited
0
-100.0%
$00.0%$19.05
0
2019-Q3
Increased
24,908
+20.6%
$397,0000.0%$15.90
28
2019-Q2
Decreased
20,645
-34.7%
$302,0000.0%$14.64
0
2019-Q1
First report
31,621
-
$622,0000.0%$20.35
0

Other major holders of MRNA: Baillie Gifford & Co.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used